NASDAQ : EMBC
Embecta Corp. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 6.56 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 371.69M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 354.12M |
| Enterprise Value | 1.64B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | Aug 27, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 56.66M |
| Shares Outstanding | 56.66M |
| Shares Change (YoY) | +1.36% |
| Shares Change (QoQ) | -1.33% |
| Owned by Insiders (%) | 3.31% |
| Owned by Institutions (%) | 90.20% |
| Float | 54.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 4.25 |
| Forward PE | 3.89 |
| PS Ratio | 0.35 |
| Forward PS | 0.33 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.15 |
| P/OCF Ratio | 2.03 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 18.76 |
| EV / Sales | 1.61 |
| EV / EBITDA | 5.83 |
| EV / EBIT | 6.92 |
| EV / FCF | 9.97 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.68 |
| Quick Ratio | 0.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.21 |
| Debt / FCF | 9.12 |
| Interest Coverage | 2.36 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.24% |
| Return on Invested Capital (ROIC) | 20.41% |
| Return on Capital Employed (ROCE) | 28.07% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | $550,649 |
| Profits Per Employee | $47,297 |
| Employee Count | 1,850 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 2.10 |
Taxes
| Measure | Value |
|---|
| Income Tax | 37.50M |
| Effective Tax Rate | 30.00% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -54.01% |
| 50-Day Moving Average | 5.74 |
| 200-Day Moving Average | 6.44 |
| Relative Strength Index (RSI) | 52.19 |
| Average Volume (20 Days) | 894,218 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.87M |
| Short Previous Month | 5.83M |
| Short % of Shares Out | 10.36% |
| Short % of Float | 10.72% |
| Short Ratio (days to cover) | 5.82 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.02B |
| Gross Profit | 595.10M |
| Operating Income | 237.30M |
| Pretax Income | 125.00M |
| Net Income | 87.50M |
| EBITDA | 281.50M |
| EBIT | 237.30M |
| Earnings Per Share (EPS) | $1.47 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 214.70M |
| Total Debt | 1.50B |
| Net Cash | -1.29B |
| Net Cash Per Share | -$22.71 |
| Equity (Book Value) | -612.70M |
| Book Value Per Share | -10.81 |
| Working Capital | 285.30M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 174.10M |
| Capital Expenditures | -9.50M |
| Depreciation & Amortization | 44.20M |
| Net Borrowing | -21.50M |
| Free Cash Flow | 164.60M |
| FCF Per Share | $2.91 |
Margins
| Measure | Value |
|---|
| Gross Margin | 58.42% |
| Operating Margin | 23.29% |
| Pretax Margin | 12.27% |
| Profit Margin | 8.59% |
| EBITDA Margin | 27.63% |
| EBIT Margin | 23.29% |
| FCF Margin | 16.16% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | -46.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.78% |
| FCF Payout Ratio | 11.02% |
| Buyback Yield | -1.36% |
| Shareholder Yield | -0.72% |
| Earnings Yield | 23.51% |
| FCF Yield | 46.48% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.00 |
| Price Target Difference | -36.00% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 0.21% |
| EPS Growth Forecast (3Y) | -12.89% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |